Hemoadsorption by CytoSorb in septic patients: a case series
Abstract Background Septic shock, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, is a highly lethal condition that causes substantial morbidity and mortality among critically ill patients. One of the hallmarks of sepsis is the excessive release of...
Main Authors: | Klaus Kogelmann, Dominik Jarczak, Morten Scheller, Matthias Drüner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-03-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-017-1662-9 |
Similar Items
-
First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock
by: Klaus Kogelmann, et al.
Published: (2021-06-01) -
Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
by: Christopher Rugg, et al.
Published: (2020-11-01) -
Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient
by: Alarie, M., et al.
Published: (2022) -
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
by: Elettra C Poli, et al.
Published: (2019-04-01) -
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
by: Patrick M. Honore, et al.
Published: (2020-07-01)